berberine has been researched along with Pain, Chronic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Morphine tolerance remains a challenge in the management of chronic pain in the clinic." | 3.88 | Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner. ( Bao, YN; Dai, WL; Jiang, N; Liu, JH; Liu, XT; Yan, B; Yu, BY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, WL | 1 |
| Liu, XT | 1 |
| Bao, YN | 1 |
| Yan, B | 1 |
| Jiang, N | 1 |
| Yu, BY | 1 |
| Liu, JH | 1 |
1 other study available for berberine and Pain, Chronic
| Article | Year |
|---|---|
Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner.
Topics: Analgesics, Opioid; Animals; Berberine; Cell Line, Tumor; CHO Cells; Chronic Pain; Cricetinae; Crice | 2018 |